Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Fever × Dermatologic × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

NETWORK 3 OTHER 1 NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 8 Other hematologic neoplasm 7 Lymphoid 3 Gynecologic 3 Genitourinary 3 Sarcoma 1 Plasma cell 1 NET 1 Gastrointestinal 1 Endocrine 1 Dermatologic 1

Conditions

Melanoma 1481 Skin Neoplasms 319 Lymphoma, T-Cell, Cutaneous 294 Carcinoma, Basal Cell 210 Mycosis Fungoides 206 Sezary Syndrome 189 Lymphoma, Non-Hodgkin 175 Leukemia, Lymphocytic, Chronic, B-Cell 173 Breast Neoplasms 173 Lymphoma, Follicular 167 Precursor Cell Lymphoblastic Leukemia-Lymphoma 165 Lymphoma, Large B-Cell, Diffuse 164 Lymphoma, Mantle-Cell 162 Lymphoma, B-Cell, Marginal Zone 162 Lymphoma 159 Burkitt Lymphoma 156 Hodgkin Disease 155 Lymphoma, Large-Cell, Immunoblastic 154 Uveal Melanoma 149 Multiple Myeloma 144 Keratosis, Actinic 135 Neoplasms 124 Leukemia, Myeloid, Acute 120 Neoplasm Metastasis 110 Lymphoma, Large-Cell, Anaplastic 110 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 109 Lung Neoplasms 105 Immunoblastic Lymphadenopathy 103 Leukemia, Myeloid, Accelerated Phase 101 Leukemia, Myeloid, Chronic-Phase 100

Interventions

trametinib 1 dabrafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01972347 2025-12-16

Neo Combi

Melanoma Institute Australia

Phase 2 Active not recruiting

Fever, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡